Health Catalyst, Inc.

Equities

HCAT

US42225T1079

Software

Market Closed - Nasdaq 04:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
7.44 USD -0.67% Intraday chart for Health Catalyst, Inc. -7.58% -19.65%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Health Catalyst, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 10:15 AM
Health Catalyst Shares Rise After CEO Stock Purchase MT
Transcript : Health Catalyst, Inc. - Special Call
KeyBanc Cuts Price Target on Health Catalyst to $10 From $12, Keeps Overweight Rating MT
Evercore ISI Adjusts Price Target on Health Catalyst to $10 From $11, Maintains Outperform Rating MT
Canaccord Genuity Trims Price Target on Health Catalyst to $11 From $12, Maintains Buy Rating MT
Transcript : Health Catalyst, Inc., Q4 2023 Earnings Call, Feb 22, 2024
Earnings Flash (HCAT) HEALTH CATALYST Posts Q4 EPS $0.02, vs. Street Est of $-0.01 MT
Health Catalyst, Inc. Announces CFO Changes, Effective March 1, 2024 CI
Health Catalyst, Inc. Announces Board Changes, Effective March 1, 2024 CI
Health Catalyst, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Earnings Flash (HCAT) HEALTH CATALYST Posts Q4 Revenue $75.1M, vs. Street Est of $73.6M MT
Health Catalyst, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024 CI
Health Catalyst, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
North American Morning Briefing : Cautious Start -2- DJ
Guggenheim Upgrades Health Catalyst to Buy From Neutral, Price Target is $14 MT
Transcript : Health Catalyst, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 01:30 PM
SacValley Medshare Selects Health Catalyst to Power Its Qualified Health Information Organization CI
North American Morning Briefing : S&P 500 Futures -2- DJ
Evercore ISI Upgrades Health Catalyst to Outperform From In-Line, Raises Price Target to $11 From $9 MT
Piper Sandler Adjusts Health Catalyst Price Target to $12 From $11, Maintains Overweight Rating MT
North American Morning Briefing : Dow Set For New -2- DJ
JPMorgan Upgrades Health Catalyst to Overweight From Neutral, Cuts Price Target to $11 From $14 MT
North American Morning Briefing : Caution -2- DJ
Piper Sandler Upgrades Health Catalyst to Overweight From Neutral, Trims Price Target to $11 From $12 MT
Chart Health Catalyst, Inc.
More charts
Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company's solutions comprise a cloud-based data platform, software analytics applications, and professional services capabilities. The Company operates through two segments: Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and is focused primarily on contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its customers to fully configure and utilize the benefits of its technology offerings. Its customers are primarily healthcare providers.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
7.44 USD
Average target price
11.93 USD
Spread / Average Target
+60.39%
Consensus